Meritage Homes Corp
SWB:MEY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Meritage Homes Corp
SWB:MEY
|
US |
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
US |
|
AVROBIO Inc
NASDAQ:TECX
|
US |
|
S
|
Shin-Etsu Chemical Co Ltd
XBER:SEH
|
JP |
Wall St Price Targets
MEY Price Targets Summary
Meritage Homes Corp
According to Wall Street analysts, the average 1-year price target for
MEY is 67.62 EUR with a low forecast of 52.52 EUR and a high forecast of 81.6 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MEY's stock price target?
Price Target
67.62
EUR
According to Wall Street analysts, the average 1-year price target for
MEY is 67.62 EUR with a low forecast of 52.52 EUR and a high forecast of 81.6 EUR.
What is the Revenue forecast for Meritage Homes Corp?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Meritage Homes Corp?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 20%.
What is the Operating Income forecast for Meritage Homes Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 3 years is 4%.
What is the Pre-Tax Income forecast for Meritage Homes Corp?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 3%.
What is the Net Income forecast for Meritage Homes Corp?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 2%.